Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Manufacturer of Motors, Powered Surgical Devices, Motion Control Products

June 2, 2011 12:36 pm | Pro-Dex | Product Releases | Comments

Established in 1975, Pro-Dex Inc. has grown to specialize in the design, development and contract manufacture of everything from components, motors and subassemblies to complete powered surgical devices.

Masimo Initiates Limited Market Release of E1, Single-Patient-Use Ear Sensor for Pulse Oximetry Monitoring

June 2, 2011 12:34 pm | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., June 2, 2011 /- Masimo (NASDAQ: MASI ) announced today FDA 510(k) Clearance, CE Mark, and limited market release of the industry's first single-patient-use ear sensor.  Compared to digit sensors, the Masimo E1™ enables faster detection of oxygen saturation...

Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia

June 2, 2011 12:32 pm | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J. and PORTLAND, Ore., June 2, 2011 /- Medco Health Solutions, Inc. (NYSE: MHS ) and MolecularMD Corp. today announce the launch of a personalized medicine program for chronic myeloid leukemia (CML) patients.  Through this program, Medco will offer patients...

Advertisement

FDA Safety Communication: Breast Cancer Screening - Thermography is Not an Alternative to Mammography

June 2, 2011 12:30 pm | by U.S. Food & Drug Administration | News | Comments

The FDA is issuing this communication to alert the public, including women and health care providers, that thermography is not a replacement for screening mammography and should not be used by itself to diagnose breast cancer. The FDA is not aware of any

Covidien's hernia mesh gets U.S. and European OK

June 2, 2011 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Covidien plc has won approval in both the U.S. and Europe to market its Parietex Optimized Composite (PCOx) mesh used in surgical hernia repair, the company said today.

Siemens Healthcare PACS Certifies BridgeHead Software

June 2, 2011 10:34 am | by RealWire | News | Comments

BridgeHead MediStore™ proven to offer a comprehensive medical imaging archive with full disaster recovery capabilities for Siemens SYNGO usersASHTEAD, UK AND WOBURN, MA - June 02, 2011 - BridgeHead Software, a leader in healthcare data and storage management, today announced the...

Kaiser Permanente Colorado Receives Top Honor for Excellence in Medication Safety

June 2, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

DENVER, June 2, 2011 /- Kaiser Permanente Colorado is one of only three health plans in the nation to receive a top honor for excellence in medication safety. The award, issued by the Pharmacy Quality Alliance, recognizes Kaiser Permanente's outstanding performance on medication safety...

PQA Recognizes Kaiser Permanente Hawaii for Excellence in Medication Safety

June 2, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

HONOLULU, June 2, 2011 /- Kaiser Permanente Hawaii has received the inaugural Pharmacy Quality Alliance (PQA) Quality Award.  This award recognizes Kaiser Permanente's achievement of a 5-star rating on the PQA measures of medication safety that are included in the Centers for...

Advertisement

Benchmark Electronics Recognized as Supplier for 2011 Design Medical Excellence Award Winner in the Radiological and Electromechanical Devices Category

June 2, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

ANGLETON, Texas, June 2, 2011 /- Benchmark Electronics, Inc. (NYSE: BHE ), a leading integrated contract manufacturing provider, announced today that a product it helped commercialize and currently manufactures has won a 2011 Medical Design Excellence Awards. The Avedro Vedera KXS Vision...

FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer

June 2, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 2, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using...

Mylan Receives Approval for Generic Version of Effexor XR® Capsules

June 2, 2011 9:32 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, June 2, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Venlafaxine Hydrochloride (HCl)...

Commencement of GMP Production Project for Lead Anti-Cancer Product PAT-LM1

June 2, 2011 9:32 am | by Bio-Medicine.Org | News | Comments

MELBOURNE, Australia and PRINCETON, N.J., June 2, 2011 /- Patrys Limited (ASX: PAB) (the "Company"), a biopharmaceutical company focused on the development of novel treatments for cancer, is pleased to announce it has extended its relationship with Laureate Biopharmaceutical Services,...

MedInformatix RIS Enhances Lenox Hill Radiology's Practice Management Efficiencies for Better Workflow and Improved Customer Service

June 2, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 2, 2011 /- Lenox Hill Radiology is first in its field with respect to leveraging cutting-edge technology to provide a full scope of diagnostic radiology services and care to patients, as well as to New York-area physicians, healthcare practitioners, hospitals, universities...

Advertisement

Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference

June 2, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., June 2, 2011 /- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda President and CEO...

IDEV Technologies Announces Completion of SUPERB Clinical Trial Enrollment

June 2, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

WEBSTER, Texas, June 2, 2011 /- IDEV Technologies, Inc. (IDEV) today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA® stent system for treatment of peripheral artery disease in the superficial femoral artery...

Goodwin Biotechnology Announces a Collaboration With Alethia Biotherapeutics

June 2, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

PLANTATION, Fla. and MONTREAL, June 2, 2011 /- Goodwin Biotechnology, Inc. (GBI), a full service CMO focused on process development and GMP manufacturing of cell culture derived biopharmaceuticals, and Alethia Biotherapeutics, Inc., a biotechnology company focused on monoclonal antibody...

At SIIM 2011 Siemens Showcases Imaging IT Solutions for Driving Greater Value in Radiology and Other Specialties

June 2, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, June 2, 2011 /- Siemens Healthcare (NYSE: SI) will showcase its portfolio of imaging information technology (IT) and workflow management solutions at the Society for Imaging Informatics in Medicine (SIIM) 2011 Annual Meeting from June 2-5, 2011, (booth 825) in the Gaylord...

Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase

June 2, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 2, 2011 /- Citeline, the world's leading research authority on pharmaceutical clinical trials and intelligence recently completed a comprehensive review of clinical trial starts in the oncology therapeutic area to uncover trends and patterns in drug development. Over the...

Benchmark Electronics Recognized as Supplier for 2011 Design Medical Excellence Award Winner

June 2, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

ANGLETON, Texas, June 2, 2011 /- Benchmark Electronics, Inc. (NYSE: BHE ), a leading integrated contract manufacturing provider, announced today that a product it helped commercialize and currently manufactures has won the 2011 Medical Design Excellence Award and 2011 Edison Award for...

Cynosure to Present at Jefferies 2011 Global Healthcare Conference

June 2, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

WESTFORD, Mass., June 2, 2011 /- Cynosure, Inc. (NASDAQ: CYNO ), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that it will present at the Jefferies 2011 Global Healthcare Conference at 1:30 p.m. (ET) on...

Isis Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference

June 2, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., June 2, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Jefferies' 2011 Global Healthcare Conference on Thursday, June 09, 2011 at 11:30 a.m. ET at the Grand...

PLC Ramps Up for U.S. Clinical Trial of RenalGuard®

June 2, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., June 2, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that it is preparing to commence the pivotal trial in the U.S. for the company's innovative product, RenalGuard®, to seek approval for sales...

Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat

June 2, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., June 2, 2011 /- Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the United States Patent and Trademark Office of Patent Application Serial No. 12/549458 entitled: " N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL)-...

PositiveID Corporation's Pipeline Increases to Over $37 Million in Potential New Government Contracts

June 2, 2011 5:31 am | by PositiveID | News | Comments

PositiveID Corporation's Pipeline Increases to Over $37 Million in Potential New Government Contracts

Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller

June 2, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., June 2, 2011 /- Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that it recently appointed Joseph Warusz as its new Vice President of Administration and Controller. In this role, Mr. Warusz will oversee the...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading